MN

Mukesh Narayandas Harajakar

Active Director Director DIN 11409598
DIN 11409598 First appointment Dec 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mukesh Narayandas Harajakar

Data last updated:

Mukesh Narayandas Harajakar is a Director at Seynapsis Pharma Private Limited (since 2025). The company operates in Paper.

DIN 11409598
Primary Designation Director
Industry Paper
First Appointment 05 Dec 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Seynapsis Pharma Private Limited U21002PN2025PTC238417
Director05 Dec 20252025Active

Board colleagues of Mukesh Narayandas Harajakar

Directorship timeline

Open interactive timeline →
Seynapsis Pharma Private Limited
Premium access

Shareholding and investment profile for Mukesh Narayandas Harajakar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mukesh Narayandas Harajakar

Mukesh Narayandas Harajakar currently holds 1 directorship: Seynapsis Pharma Private Limited (Director, since 05 Dec 2025).

Mukesh Narayandas Harajakar was first appointed on 05 Dec 2025 as Director at Seynapsis Pharma Private Limited.

The current boards of Mukesh Narayandas Harajakar's companies include Amit Maniklal Wadhwani (Seynapsis Pharma Private Limited), Manoj Ghanshyamdas Bhutada (Seynapsis Pharma Private Limited), Navalkishor Bansilal Lakhotia (Seynapsis Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available